Fundraising FoxAbClon Venture Capital
3 known investors
Find your way into AbClon Venture Capital
Sign up to see every warm intro you have to AbClon Venture Capital
- Paths you didn't know you had: your email and LinkedIn already hold routes to the AbClon Venture Capital team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
AbClon is a biotech company developing new therapeutics, including advanced gene and cell therapies and antibody-based treatments. Its work centers on CAR-T cell therapy and antibody discovery platforms for human disease.
Investors · 3
Frequently asked questions
- What does AbClon Venture Capital do?
- AbClon is a biotech company developing new therapeutics, including advanced gene and cell therapies and antibody-based treatments. Its work centers on CAR-T cell therapy and antibody discovery platforms for human disease.
- Who are AbClon Venture Capital's investors?
- AbClon Venture Capital's investors include Aju IB Investment, IMM Investment Japan, SBI Investment Korea Co. Ltd..